ARTV logo

Artiva Biotherapeutics, Inc.

ARTV
Healthcare|Biotechnology|US
$4.15
+0.02 (+0.48%)
DCF Value
$0.66
Tangible Book / Share
$8.82
Cash / Share
$8.86
Next Earnings Report
Nov 11, 2026
EPS est. -$0.54
Financing Filings (last 12 months)
2
Shelf registrations / offering prospectuses — latest Aug 6, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (4)

Jul 2027
Est. completion
P1Rheumatoid Arthritis
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.
NCT06581562n=30
Aug 2027
Est. completion
P1Lupus Nephritis - WHO Class III
AB-101 in Combination With B-Cell Depleting mAb in Patients Who Failed Treatment for Class III or IV Lupus Nephritis or Other Forms of Refractory Systemic Lupus Erythematosus
NCT06265220n=51
Aug 2027
Est. completion
P1Lymphoma, T-Cell
Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies
NCT06699771n=53
Jan 2028
Est. completion
P2Refractory Rheumatoid Arthritis (RA)
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
NCT06991114n=90

Recent Press Releases

Artiva Biotherapeutics Announces Strategic Update and Discontinues Development of AlloNK®
Oct 27, 2026 · GlobeNewsWire
Artiva Biotherapeutics Announces Multiple AlloNK® Data Presentations at the American College of Rheumatology (ACR) Convergence 2026
Oct 2, 2026 · GlobeNewsWire
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren's Disease (ISSjD 2026)
Oct 1, 2026 · GlobeNewsWire
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren's Disease
Sep 23, 2026 · GlobeNewsWire
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
Sep 17, 2026 · GlobeNewsWire
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
Sep 8, 2026 · GlobeNewsWire
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
Sep 2, 2026 · GlobeNewsWire

SEC Filings (53)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 27, 20268-KMaterial eventDocumentIndex
Sep 11, 2026S-8Employee stock planDocumentIndex
Sep 11, 20268-KMaterial eventDocumentIndex
Aug 14, 2026EFFECTDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 10, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 6, 2026S-3Shelf registrationDocumentIndex
Aug 6, 202610-QQuarterly reportDocumentIndex
Aug 6, 20268-KMaterial eventDocumentIndex
Aug 3, 2026ARSAnnual report to holdersDocumentIndex
Aug 3, 2026DEF 14AProxy / shareholder voteDocumentIndex
Jul 23, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
Jul 22, 20268-KMaterial eventDocumentIndex
Jun 15, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 28, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 19, 20268-KMaterial eventDocumentIndex
May 18, 2026SC 13GPassive 5%+ stakeDocumentIndex
May 13, 2026SC 13D/AActivist / 5%+ stakeDocumentIndex
May 8, 20268-KMaterial eventDocumentIndex
May 8, 2026424B5Offering prospectusDocumentIndex
May 8, 2026FWPDocumentIndex
May 8, 202610-QQuarterly reportDocumentIndex
May 8, 20268-KMaterial eventDocumentIndex
Apr 30, 202610-K/AAnnual reportDocumentIndex
Mar 10, 2026S-8Employee stock planDocumentIndex
Mar 10, 202610-KAnnual reportDocumentIndex
Mar 10, 20268-KMaterial eventDocumentIndex
Feb 24, 20268-KMaterial eventDocumentIndex
Feb 19, 20268-KMaterial eventDocumentIndex
Dec 12, 20258-KMaterial eventDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Nov 12, 202510-QQuarterly reportDocumentIndex
Nov 12, 20258-KMaterial eventDocumentIndex
Aug 15, 2025EFFECTDocumentIndex
Aug 6, 2025S-3Shelf registrationDocumentIndex
Aug 6, 2025S-8Employee stock planDocumentIndex
Aug 6, 202510-QQuarterly reportDocumentIndex
Aug 6, 20258-KMaterial eventDocumentIndex
Jul 16, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jun 25, 20258-KMaterial eventDocumentIndex